Quidel Corporation (NASDAQ: QDEL) announced today financial results for its third quarter ended September 30, 2010.
Third Quarter 2010 Results
For the third quarter of 2010, total revenues were $28.2 million, compared to $56.2...(
read more)
Shares of Quidel Corporation (NASDAQ: QDEL), jumped more than 6% after it announced that it has received 510(k) clearance from the United States Food and Drug Administration for the sale of its...(
read more)
With healthcare legislation at the forefront of investors’ minds right now, it’s only natural to expect a short-term rally in the medical supply stocks that are due to see increased sales volume at the hands of a...(
read more)